Wirtz Veronika J, Reich Michael R, Leyva Flores René, Dreser Anahí
Centro de Investigación en Sistemas de Salud, Instituto Nacional de Salud Pública, México.
Salud Publica Mex. 2008;50 Suppl 4:S470-9. doi: 10.1590/s0036-36342008001000008.
To review original research studies published between 1990 and 2004 on the access and use of medicines in Mexico to assess the knowledge base for reforming Mexico's pharmaceutical policy.
A literature review using electronic databases was conducted of original studies published in the last 15 years about access and use of medicines in Mexico. In addition, a manual search of six relevant journals was performed. Excluded were publications on herbal, complementary and alternative medicines.
Were identified 108 original articles as being relevant, out of 2289 titles reviewed, highlighting four policy-related problems: irrational prescribing, harmful self-medication, inequitable access, and frequent drug stock shortage in public health centers.
This review identified two priorities for Mexico's pharmaceutical policy and strategies: tackling the irrational use of medicines and the inadequate access of medicines. These are critical priorities for a new national pharmaceutical policy.
回顾1990年至2004年间发表的关于墨西哥药品获取与使用情况的原创性研究，以评估改革墨西哥药品政策的知识基础。
通过电子数据库对过去15年发表的有关墨西哥药品获取与使用情况的原创性研究进行文献综述。此外，还手动检索了六种相关期刊。排除了关于草药、补充替代医学的出版物。
在检索的2289篇文献标题中，确定了108篇相关原创文章，突出了四个与政策相关的问题：不合理用药、有害的自我药疗、不公平的药品获取以及公共卫生中心频繁的药品库存短缺。
本综述确定了墨西哥药品政策和战略的两个优先事项：解决药品的不合理使用以及药品获取不足的问题。这些是新的国家药品政策的关键优先事项。
